Biotech startups that raised a seed round in DACH
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| smartbax | Munich | Seed | $5.5M | 2026-06-30 |
| Graph Therapeutics | Klosterneuburg | Seed | $5.0M | 2026-06-22 |
| Tacalyx | Berlin | Seed | $12.9M | 2026-04-29 |
| Omegga GmbH | Munich | Seed | $11.7M | 2026-04-24 |
| Cellbricks Therapeutics | Berlin | Seed | $8.1M | 2026-03-25 |
| Alithea Genomics | Lausanne | Seed | $3.8M | 2026-03-04 |
| Innocent Meat | Rostock | Seed | $7.1M | 2026-01-22 |
| FluoSphera | Geneva | Seed | $1.4M | 2026-01-12 |
8 rows of the CSV in 5 of its 18 columns.
- The 216 biotech startups in DACH whose last round is a seed round have raised $440.4M in total.
- 32 of them closed their most recent round in the last 12 months, $156.0M combined.
- The largest of those rounds is SRTD Biotech's $35.2M seed round, dated November 2026.
- HTGF (High-Tech Gruenderfonds) is an investor in 33 of them, more than any other fund.
- Health care is the most common other sector, with 148 companies (69%).
- 43% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 1 to 10 employees (63% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 216| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| smartbax | Smartbax develops multi-targeted antibacterial compounds that are potent against multi-drug resistant bacteria. | Biotech | Munich, Germany | Seed | $5.5M | 2026-06-30 | $7.5M | HTGF (High-Tech Gruenderfonds), Boehringer Ingelheim Venture Fund | 1 to 10 | 2021 |
| Graph Therapeutics | Graph Therapeutics uses AI and multi-omics analysis of patient cells to develop precision immunology treatments. | Artificial intelligence | Klosterneuburg, Austria | Seed | $5.0M | 2026-06-22 | $9.4M | SquareOne Venture Capital, Merantix Capital | 1 to 10 | 2024 |
| Tacalyx | Tacalyx develops cancer therapies that target tumor-associated carbohydrate antigens. | Biotech | Berlin, Germany | Seed | $12.9M | 2026-04-29 | $28.0M | HTGF (High-Tech Gruenderfonds), coparion, Kurma Partners +2 | 1 to 10 | 2019 |
| Omegga GmbH | Omegga GmbH develops in-ovo sexing technology that identifies male chicks before hatching to prevent their killing. | Artificial intelligence | Munich, Germany | Seed | $11.7M | 2026-04-24 | $11.7M | EIC Accelerator, GETTY | 1 to 10 | 2022 |
| Cellbricks Therapeutics | Cellbricks Therapeutics is a biotech company developing methods for replacing tissue and organs. | Biotech | Berlin, Germany | Seed | $8.1M | 2026-03-25 | $11.6M | b.value AG, Brooks Hill Partners | 11 to 50 | 2016 |
| Alithea Genomics | Alithea Genomics develops molecular biology tools and sequencing solutions for large-scale gene expression analysis. | Biotech | Lausanne, Switzerland | Seed | $3.8M | 2026-03-04 | $9.9M | Foundation for Innovation and Technology (FIT), TechU Ventures, Eurostars +1 | 11 to 50 | 2020 |
| Innocent Meat | Innocent Meat provides plug-and-play technology that converts meat producers into cell-based producers. | Biotech | Rostock, Germany | Seed | $7.1M | 2026-01-22 | $11.0M | Big Idea Ventures, GENIUS Venture Capital | 1 to 10 | 2020 |
| FluoSphera | FluoSphera develops drugs. | Biotech | Geneva, Switzerland | Seed | $1.4M | 2026-01-12 | $3.9M | SOSV, SOSV SF & NY (Fka IndieBio), FONGIT Innovation Fund +2 | 1 to 10 | 2021 |
| Hemostod | HemostOD manufactures platelets on demand from engineered stem cells. | Biotech | Lausanne, Switzerland | Seed | $5.4M | 2025-10-01 | $7.8M | Foundation for Innovation and Technology (FIT) | 11 to 50 | 2020 |
| Abrinca Genomics | Abrinca Genomics is a biotechnology company. | Biotech | Bern, Switzerland | Seed | $178K | 2024-09-16 | Venture Kick | 1 to 10 | 2023 | |
| HELLO INSIDE | HELLO INSIDE is a scientific self-care company that helps people hold data-driven conversations with their bodies. | Biotech | Vienna, Austria | Seed | $1.8M | 2024-09-09 | Possible Ventures, 10x Founders | 11 to 50 | 2021 | |
| Biolyz | Biolyz provides AI-driven bioanalytics for athletes. | Artificial intelligence | Tulln, Austria | Seed | $1.0M | 2024-08-27 | $1.7M | Atrinum. | Ventures | 1 to 10 | 2021 |
| Lignopure GmbH | Lignopure GmbH supplies plant-based lignin ingredients for high-value markets. | Biotech | Hamburg, Germany | Seed | $2.6M | 2024-07-17 | HTGF (High-Tech Gruenderfonds), NBank Capital, Raakwark Kaptaal +1 | 11 to 50 | 2019 | |
| Cultimate Foods | Cultimate Foods is a cellular agriculture company. | Biotech | Berlin, Germany | Seed | $2.5M | 2024-04-23 | HTGF (High-Tech Gruenderfonds), MassChallenge Switzerland, Big Idea Ventures +2 | 1 to 10 | 2022 | |
| FundaMental Pharma | FundaMental Pharma is a neuroscience company with preclinical-stage drug candidates. | Biotech | Heidelberg, Germany | Seed | $2.9M | 2024-04-11 | $13.3M | HTGF (High-Tech Gruenderfonds), Novartis Venture Fund, coparion +2 | 1 to 10 | 2016 |
| Galventa | Galventa provides pharmaceutical manufacturing services for a micro-pellet food supplement that relieves sleep inertia symptoms. | Biotech | Saint Gallen, Switzerland | Seed | $1.8M | 2023-12-31 | Venture Kick, Founders Factory, Innosuisse +1 | 11 to 50 | 2018 | |
| Molecule | Molecule provides a software platform that helps pharmaceutical companies accelerate research and development. | Biotech | Schaffhausen, Switzerland | Seed | $1.0M | 2023-12-08 | Orange DAO, Boost VC, Protocol Labs +1 | 11 to 50 | 2019 | |
| HeartBeat.bio | HeartBeat.bio is a privately funded drug discovery company developing a high-throughput 3D screening platform. | Biotech | Vienna, Austria | Seed | $4.8M | 2023-11-02 | $6.6M | aws Gründungsfonds, Tensor Ventures, red-stars.com +2 | 11 to 50 | 2021 |
| TissueLabs | TissueLabs is a biotechnology research company that runs a platform for creating organs and tissues in the lab. | Biotech | Bellinzona, Switzerland | Seed | $800K | 2023-10-01 | $1.9M | MassChallenge Switzerland, Innosuisse, Mergus Ventures +2 | 11 to 50 | 2019 |
| Transimmune | Transimmune develops dendritic cell therapies based on its biological production of dendritic cells. | Biotech | Düsseldorf, Germany | Seed | $5.0M | 2023-09-20 | Bill & Melinda Gates Foundation | 1 to 10 | 2012 | |
| KetoSwiss | KetoSwiss is a Swiss biotech startup developing ketone body products to combat diseases. | Biotech | Basel, Switzerland | Seed | $800K | 2023-08-04 | $6.4M | R42 Group, Healthspan Capital, Baszucki Group | 1 to 10 | 2017 |
| Versameb | Versameb discovers and develops RNA-based drugs. | Biotech | Basel, Switzerland | Seed | $10.0M | 2023-06-14 | $28.1M | Bernina BioInvest | 11 to 50 | 2017 |
| DNTOX | DNTOX provides an in vitro testing battery for assessing the safety of chemicals. | Biotech | Düsseldorf, Germany | Seed | $1.5M | 2023-06-14 | HTGF (High-Tech Gruenderfonds), AQAL Integral Investing, Bool Capital | 1 to 10 | 2022 | |
| LabDAO | LabDAO is a research organization working to advance computational life sciences. | Biotech | Berlin, Germany | Seed | $3.6M | 2023-05-23 | Village Global, Orange DAO, Seed Club Ventures | 1,001 to 5,000 | 2022 | |
| faCellitate | faCellitate sells life science tools to customers in drug discovery, toxicology, industrial biotech and stem cell research. | Biotech | Mannheim, Germany | Seed | $3.7M | 2022-09-07 | HTGF (High-Tech Gruenderfonds), R3, Arve Capital | 11 to 50 | 2019 | |
| Kejako | Kejako develops a non-invasive solution helping presbyopic patients keep their quality of life. | Biotech | Geneva, Switzerland | Seed | $789K | 2022-08-01 | MassChallenge, Business Angels Switzerland (BAS), FONGIT | 1 to 10 | 2015 | |
| living brain | living brain manufactures medical devices for rehabilitation using virtual reality treatment. | Biotech | Heidelberg, Germany | Seed | $1.5M | 2022-07-11 | Companisto | 11 to 50 | 2019 | |
| Metaphysiks | Metaphysiks combines neuroscience and robotics to create multisensory immersive experiences. | Biotech | Lausanne, Switzerland | Seed | $2.0M | 2022-06-24 | The New Frontiers (TNF) | 1 to 10 | 2016 | |
| Engimmune Therapeutics | Engimmune Therapeutics engineers T cell receptor therapies and develops products based on its platform. | Biotech | Basel, Switzerland | Seed | $15.8M | 2022-05-03 | Novo Holdings, Kinled Holding, Pureos Bioventures +1 | 11 to 50 | 2021 | |
| Stromal Therapeutics | Stromal Therapeutics is a biotechnology spin-off from the Kantonsspital St.Gallen. | Biotech | Basel, Switzerland | Seed | $537K | 2022-01-28 | BaseLaunch | 1 to 10 | 2018 |
Table 1. Biotech startups that raised a seed round in DACH: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 216.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Tacalyx | Tacalyx develops cancer therapies that target tumor-associated carbohydrate antigens. | Biotech | Berlin, Germany | Seed | $12.9M | 2026-04-29 | $28.0M | HTGF (High-Tech Gruenderfonds), coparion, Kurma Partners +2 | 1 to 10 | 2019 |
| 2 | Omegga GmbH | Omegga GmbH develops in-ovo sexing technology that identifies male chicks before hatching to prevent their killing. | Artificial intelligence | Munich, Germany | Seed | $11.7M | 2026-04-24 | $11.7M | EIC Accelerator, GETTY | 1 to 10 | 2022 |
| 3 | Cellbricks Therapeutics | Cellbricks Therapeutics is a biotech company developing methods for replacing tissue and organs. | Biotech | Berlin, Germany | Seed | $8.1M | 2026-03-25 | $11.6M | b.value AG, Brooks Hill Partners | 11 to 50 | 2016 |
| 4 | Innocent Meat | Innocent Meat provides plug-and-play technology that converts meat producers into cell-based producers. | Biotech | Rostock, Germany | Seed | $7.1M | 2026-01-22 | $11.0M | Big Idea Ventures, GENIUS Venture Capital | 1 to 10 | 2020 |
| 5 | smartbax | Smartbax develops multi-targeted antibacterial compounds that are potent against multi-drug resistant bacteria. | Biotech | Munich, Germany | Seed | $5.5M | 2026-06-30 | $7.5M | HTGF (High-Tech Gruenderfonds), Boehringer Ingelheim Venture Fund | 1 to 10 | 2021 |
| 6 | Graph Therapeutics | Graph Therapeutics uses AI and multi-omics analysis of patient cells to develop precision immunology treatments. | Artificial intelligence | Klosterneuburg, Austria | Seed | $5.0M | 2026-06-22 | $9.4M | SquareOne Venture Capital, Merantix Capital | 1 to 10 | 2024 |
| 7 | Alithea Genomics | Alithea Genomics develops molecular biology tools and sequencing solutions for large-scale gene expression analysis. | Biotech | Lausanne, Switzerland | Seed | $3.8M | 2026-03-04 | $9.9M | Foundation for Innovation and Technology (FIT), TechU Ventures, Eurostars +1 | 11 to 50 | 2020 |
| 8 | FluoSphera | FluoSphera develops drugs. | Biotech | Geneva, Switzerland | Seed | $1.4M | 2026-01-12 | $3.9M | SOSV, SOSV SF & NY (Fka IndieBio), FONGIT Innovation Fund +2 | 1 to 10 | 2021 |
Table 2. Biotech startups that raised a seed round in DACH: the 8 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | 33 | 15% | 2 | smartbax, Tacalyx |
| 2 | Venture Kick | Startup incubator | Schlieren, Switzerland | 13 | 6% | ||
| 3 | b.value AG | Venture capital firm | Dortmund, Germany | 4 | 2% | 1 | Cellbricks Therapeutics |
| 4 | bmp Ventures | Venture capital firm | Berlin, Germany | 4 | 2% | ||
| 5 | Foundation for Innovation and Technology (FIT) | Entrepreneurship program | Lausanne, Switzerland | 3 | 1% | 1 | Alithea Genomics |
| 6 | Y Combinator | Startup accelerator | Mountain View, United States | 3 | 1% | ||
| 7 | MassChallenge | Startup accelerator | Boston, United States | 3 | 1% | ||
| 8 | IFB Innovationsstarter | Venture capital firm | Hamburg, Germany | 3 | 1% | ||
| 9 | Eclosion SA | Venture capital firm | Geneva, Switzerland | 3 | 1% | ||
| 10 | Boehringer Ingelheim Venture Fund | Corporate venture arm | Ingelheim Am Rhein, Germany | 2 | 1% | 2 | smartbax, Tacalyx |
| 11 | Merantix Capital | Venture capital firm | Berlin, Germany | 2 | 1% | 1 | Graph Therapeutics |
| 12 | Thuja Capital | Startup accelerator | Utrecht, The Netherlands | 2 | 1% | 1 | Tacalyx |
| 13 | coparion | Startup accelerator | Cologne, Germany | 2 | 1% | 1 | Tacalyx |
| 14 | Big Idea Ventures | Startup accelerator | New York, United States | 2 | 1% | 1 | Innocent Meat |
| 15 | SOSV | Venture capital firm | Princeton, United States | 2 | 1% | 1 | FluoSphera |
Table 3. Biotech startups that raised a seed round in DACH: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 148 | 69% | $322.8M |
| Software | 39 | 18% | $57.2M |
| Artificial intelligence | 20 | 9% | $23.4M |
| Hardware | 13 | 6% | $30.0M |
| Education | 2 | 1% | $3.6M |
| Fintech | 2 | 1% | $2.2M |
| Commerce | 1 | 0% | $4.7M |
| Cybersecurity | 1 | 0% | $4.7M |
Table 4. Biotech startups that raised a seed round in DACH by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Seed | 216 | 100% | $2.6M |
Table 5. Biotech startups that raised a seed round in DACH by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| Germany | 119 | 55% |
| Switzerland | 67 | 31% |
| Austria | 30 | 14% |
Table 6. Biotech startups that raised a seed round in DACH by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Berlin | 30 | 14% |
| Zürich | 15 | 7% |
| Vienna | 12 | 6% |
| Lausanne | 10 | 5% |
| Munich | 9 | 4% |
| Basel | 7 | 3% |
| Heidelberg | 6 | 3% |
| Hamburg | 6 | 3% |
| Geneva | 6 | 3% |
| Tulln | 5 | 2% |
| Dresden | 5 | 2% |
| Cologne | 4 | 2% |
Table 7. Biotech startups that raised a seed round in DACH by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 2 | 6% | $35.3M |
| September 2026 | 4 | 12% | $6.1M |
| August 2026 | 2 | 6% | $7.0M |
| June 2026 | 3 | 9% | $10.5M |
| May 2026 | 3 | 9% | $7.2M |
| April 2026 | 6 | 19% | $32.4M |
| March 2026 | 4 | 12% | $22.3M |
| February 2026 | 1 | 3% | |
| January 2026 | 4 | 12% | $23.6M |
| December 2025 | 2 | 6% | $11.5M |
| November 2025 | 1 | 3% |
Table 8. Biotech startups that raised a seed round in DACH: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 29 | 13% | $144.5M |
| 2025 | 28 | 13% | $111.9M |
| 2024 | 29 | 13% | $67.6M |
| 2023 | 17 | 8% | $44.2M |
| 2022 | 26 | 12% | $77.0M |
| 2021 | 14 | 6% | $20.5M |
Table 9. Biotech startups that raised a seed round in DACH by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 30 | 14% |
| 2020 to 2022 | 62 | 29% |
| 2015 to 2019 | 83 | 39% |
| 2010 to 2014 | 17 | 8% |
| Before 2010 | 21 | 10% |
Table 10. Biotech startups that raised a seed round in DACH by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 135 | 63% |
| 11 to 50 | 75 | 35% |
| 51 to 100 | 3 | 1% |
| 101 to 250 | 1 | 0% |
| 1,001 to 5,000 | 1 | 0% |
Table 11. Biotech startups that raised a seed round in DACH by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is a seed round and its headquarters is in DACH. On 16 November 2026 that is 216 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 216 rows: 82 have no round amount, 0 no city and 93 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in DACH whose last round is a seed round are on the list?
- 216, in the file dated 16 November 2026. 32 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 216 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.